Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Antineoplastic Combined Chemotherapy Protocols (2)
- Carcinoma (2)
- Carcinoma, Small Cell (2)
- Female (2)
- Humans (2)
-
- Lung Neoplasms (2)
- Male (2)
- Middle Aged (2)
- Neoplasm Staging (2)
- Retrospective Studies (2)
- Small Cell (2)
- 80 and over (1)
- Actuarial Analysis (1)
- Adjuvant (1)
- Adult (1)
- Aged (1)
- Breast Diseases (1)
- Chemotherapy (1)
- Chemotherapy, Adjuvant (1)
- Cisplatin (1)
- Cyclophosphamide (1)
- Dose Fractionation (1)
- Doxorubicin (1)
- Etoposide (1)
- Histopathological analysis (1)
- Multivariate Analysis (1)
- Radiotherapy (1)
- Radiotherapy, Adjuvant (1)
- Rural Health (1)
- Smoking (1)
- Publication
- Publication Type
- File Type
Articles 1 - 4 of 4
Full-Text Articles in Oncology
Shifting From Hypofractionated To "Conventionally" Fractionated Thoracic Radiotherapy: A Single Institution's 10-Year Experience In The Management Of Limited-Stage Small-Cell Lung Cancer Using Concurrent Chemoradiation, Gregory Videtic, Pauline Truong, A. Dar, Edward Yu, Larry Stitt
Shifting From Hypofractionated To "Conventionally" Fractionated Thoracic Radiotherapy: A Single Institution's 10-Year Experience In The Management Of Limited-Stage Small-Cell Lung Cancer Using Concurrent Chemoradiation, Gregory Videtic, Pauline Truong, A. Dar, Edward Yu, Larry Stitt
Edward Yu
PURPOSE: To perform a retrospective review of a single institution's 10-year experience in treating limited-stage small-cell lung cancer (LS-SCLC) with a concurrent chemoradiation regimen modeled after the experimental arm of a randomized National Cancer Institute of Canada trial in which hypofractionated radiotherapy started with cycle 2 of chemotherapy. We then looked at the impact on patient outcomes of changing the RT during the course of the decade to a "conventionally" (2 Gy) fractionated regimen, with a focus on toxicity and survival rates. METHODS AND MATERIALS: Between 1989 and 1999, 215 LS-SCLC patients received six cycles of chemotherapy consisting of cyclophosphamide, …
Ua61/6 Newsletter, Issue 2, Wku Institute For Rural Health Development & Research
Ua61/6 Newsletter, Issue 2, Wku Institute For Rural Health Development & Research
WKU Archives Records
Newsletter created by and about the Institute for Rural Health Development & Research. This issue contains:
- College of Health & Human Services Has New Dean – John Bonaguro
- Simpson, Staci. Institute Aims to Improve Oral Health of Children
- Whitfield, Beth. WKU Mobile Unit KICS Off Dental Event with Webster County – Kentucky Interdisciplinary Community Screening
- Stone, Glynda. TEACH KY: Teachers Exploring & Advocating Careers in Health in Kentucky
- Institute Sponsors Hispanic Health Fair
- HIV Prevention Counseling & Testing Training Program Initiated at WKU
- New Web-based Course Offered Through Communications Disorders Department at WKU
- Lashley, Donita. Child Passenger Safety Training
- Handy, …
Continued Cigarette Smoking By Patients Receiving Concurrent Chemoradiotherapy For Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival, Gregory Videtic, Larry Stitt, A. Dar, Walter Kocha, Anna Tomiak, Pauline Truong, Mark Vincent, Edward Yu
Continued Cigarette Smoking By Patients Receiving Concurrent Chemoradiotherapy For Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival, Gregory Videtic, Larry Stitt, A. Dar, Walter Kocha, Anna Tomiak, Pauline Truong, Mark Vincent, Edward Yu
Edward Yu
PURPOSE: To determine the impact of continued smoking by patients receiving chemotherapy (CHT) and radiotherapy (RT) for limited-stage small-cell lung cancer (LSCLC) on toxicity and survival. PATIENTS AND METHODS: A retrospective review was carried out on 215 patients with LSCLC treated between 1989 and 1999. Treatment consisted of six cycles of alternating cyclophosphamide, doxorubicin, vincristine and etoposide, cisplatin (EP). Thoracic RT was concurrent with EP (cycle 2 or 3) only. Patients were known smokers, with their smoking status recorded at the start of chemoradiotherapy (CHT/RT). RT interruption during concurrent CHT/RT was used as the marker for treatment toxicity. RESULTS: Of …
Breast Diseases: A Histopathological Analysis Of 3279 Cases At A Tertiary Care Center In Pakistan, M. S. Siddiqui, Naila Kayani, Shahid Pervez, S. A. Aziz, S. Muzaffar, Z. Setna, M. Israr, S. H. Hasan, M. S. Gill
Breast Diseases: A Histopathological Analysis Of 3279 Cases At A Tertiary Care Center In Pakistan, M. S. Siddiqui, Naila Kayani, Shahid Pervez, S. A. Aziz, S. Muzaffar, Z. Setna, M. Israr, S. H. Hasan, M. S. Gill
Department of Pathology and Laboratory Medicine
Objective: To know the frequency of breast diseases in Pakistani females.
Methods: A retrospective analysis of 3279 breast specimens received over a period of 4 years (1 993-1996) at the department of pathology, the Aga Khan University Hospital.
Results: Out of a total of 3279 breast specimens, common breast lesions included infiltrating duct carcinoma 37%, followed by fibro adenoma 16.95%, fibrocystic change13.96%, mastitis 6.83% and duct ectasia 5.33%. Majority of the cases of infiltrating duct carcinoma were encountered in the 5th and 6th decades of life. Tumour size was 2 or >2 cms. in 93% of cases and 40% of …